ARTICLE | Distillery Therapeutics
Neurology
August 16, 2018 4:10 PM UTC
Mouse studies suggest optogenetically activating or agonizing 5-HT1B receptors on neurons projecting from the dorsal raphe to the nucleus accumbens could help treat autism spectrum disorders (ASDs) ca...
BCIQ Company Profiles